BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 20816973)

  • 1. Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency.
    Marsh RA; Bleesing JJ; Filipovich AH
    J Immunol Methods; 2010 Oct; 362(1-2):1-9. PubMed ID: 20816973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-linked lymphoproliferative syndrome in mainland China: review of clinical, genetic, and immunological characteristic.
    Xu T; Zhao Q; Li W; Chen X; Xue X; Chen Z; Du X; Bai X; Zhao Q; Zhou L; Tang X; Yang X; Kanegane H; Zhao X
    Eur J Pediatr; 2020 Feb; 179(2):327-338. PubMed ID: 31754776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency.
    Wada T; Kanegane H; Ohta K; Katoh F; Imamura T; Nakazawa Y; Miyashita R; Hara J; Hamamoto K; Yang X; Filipovich AH; Marsh RA; Yachie A
    Cytokine; 2014 Jan; 65(1):74-8. PubMed ID: 24084330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid flow cytometric screening test for X-linked lymphoproliferative disease due to XIAP deficiency.
    Marsh RA; Villanueva J; Zhang K; Snow AL; Su HC; Madden L; Mody R; Kitchen B; Marmer D; Jordan MB; Risma KA; Filipovich AH; Bleesing JJ
    Cytometry B Clin Cytom; 2009 Sep; 76(5):334-44. PubMed ID: 19288545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early and rapid detection of X-linked lymphoproliferative syndrome with SH2D1A mutations by flow cytometry.
    Zhao M; Kanegane H; Kobayashi C; Nakazawa Y; Ishii E; Kasai M; Terui K; Gocho Y; Imai K; Kiyasu J; Nonoyama S; Miyawaki T
    Cytometry B Clin Cytom; 2011 Jan; 80(1):8-13. PubMed ID: 20632414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease.
    Marsh RA; Madden L; Kitchen BJ; Mody R; McClimon B; Jordan MB; Bleesing JJ; Zhang K; Filipovich AH
    Blood; 2010 Aug; 116(7):1079-82. PubMed ID: 20489057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SAP and XIAP deficiency in hemophagocytic lymphohistiocytosis.
    Yang X; Miyawaki T; Kanegane H
    Pediatr Int; 2012 Aug; 54(4):447-54. PubMed ID: 22672194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency).
    Pachlopnik Schmid J; Canioni D; Moshous D; Touzot F; Mahlaoui N; Hauck F; Kanegane H; Lopez-Granados E; Mejstrikova E; Pellier I; Galicier L; Galambrun C; Barlogis V; Bordigoni P; Fourmaintraux A; Hamidou M; Dabadie A; Le Deist F; Haerynck F; Ouachée-Chardin M; Rohrlich P; Stephan JL; Lenoir C; Rigaud S; Lambert N; Milili M; Schiff C; Chapel H; Picard C; de Saint Basile G; Blanche S; Fischer A; Latour S
    Blood; 2011 Feb; 117(5):1522-9. PubMed ID: 21119115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical flow cytometric screening of SAP and XIAP expression accurately identifies patients with SH2D1A and XIAP/BIRC4 mutations.
    Gifford CE; Weingartner E; Villanueva J; Johnson J; Zhang K; Filipovich AH; Bleesing JJ; Marsh RA
    Cytometry B Clin Cytom; 2014 Jul; 86(4):263-71. PubMed ID: 24616127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation-dependent T cell expression of the X-linked lymphoproliferative disease gene product SLAM-associated protein and its assessment for patient detection.
    Shinozaki K; Kanegane H; Matsukura H; Sumazaki R; Tsuchida M; Makita M; Kimoto Y; Kanai R; Tsumura K; Kondoh T; Moriuchi H; Miyawaki T
    Int Immunol; 2002 Oct; 14(10):1215-23. PubMed ID: 12356686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable clinical phenotypes of X-linked lymphoproliferative syndrome in China: Report of five cases with three novel mutations and review of the literature.
    Jin YY; Zhou W; Tian ZQ; Chen TX
    Hum Immunol; 2016 Aug; 77(8):658-666. PubMed ID: 27288720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and genetic features of 5 Chinese patients with X-linked lymphoproliferative syndrome.
    Sun J; Ying W; Liu D; Hui X; Yu Y; Wang J; Wang X
    Scand J Immunol; 2013 Nov; 78(5):463-7. PubMed ID: 23944711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members.
    Tabata Y; Villanueva J; Lee SM; Zhang K; Kanegane H; Miyawaki T; Sumegi J; Filipovich AH
    Blood; 2005 Apr; 105(8):3066-71. PubMed ID: 15632210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome.
    Rigaud S; Fondanèche MC; Lambert N; Pasquier B; Mateo V; Soulas P; Galicier L; Le Deist F; Rieux-Laucat F; Revy P; Fischer A; de Saint Basile G; Latour S
    Nature; 2006 Nov; 444(7115):110-4. PubMed ID: 17080092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With
    Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S
    Front Pediatr; 2019; 7():183. PubMed ID: 31231620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric measurement of SLAM-associated protein and X-linked inhibitor of apoptosis.
    Marsh RA; Bleesing JJ; Filipovich AH
    Methods Mol Biol; 2013; 979():189-97. PubMed ID: 23397397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein.
    Schuster V; Kreth HW
    Immunol Rev; 2000 Dec; 178():21-8. PubMed ID: 11213803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLAM-associated protein deficiency causes imbalanced early signal transduction and blocks downstream activation in T cells from X-linked lymphoproliferative disease patients.
    Sanzone S; Zeyda M; Saemann MD; Soncini M; Holter W; Fritsch G; Knapp W; Candotti F; Stulnig TM; Parolini O
    J Biol Chem; 2003 Aug; 278(32):29593-9. PubMed ID: 12766168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic differences between mice deficient in XIAP and SAP, two factors targeted in X-linked lymphoproliferative syndrome (XLP).
    Rumble JM; Oetjen KA; Stein PL; Schwartzberg PL; Moore BB; Duckett CS
    Cell Immunol; 2009; 259(1):82-9. PubMed ID: 19595300
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.